Safety and use of pulmonary function tests: a retrospective study from a single center over seven years’ clinical practice

Li, Fēi; Huang, Zhi; Wang, Xiao Fei; Xu, Huiwen; Yu, Hua; Chen, Yan Bin; Huang, Jian; Wang, Jia Jia; Lei, Wei

doi:10.1186/s12890-019-1019-z

Cited by 6 publications

(5 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In a study conducted in our country, the rate of tests meeting the acceptability criteria was 62.4% ( 9 ). In the study by Li et al in a large population in China, this rate was 98% ( 10 ). In a study conducted in Italy on the population over 65 years of age, it was observed that the acceptability rates were around 80% ( 11 ).…”

Section: Discussionmentioning

confidence: 95%

Determining factors affecting the acceptability of spirometry: A survey study in a tertiary chest diseases center

Güçsav,

Polat,

Serçe Unat

et al. 2023

Tuberk Toraks

View full text Add to dashboard Cite

Determining factors affecting the acceptability of spirometry: A survey study in a tertiary chest diseases center Introduction Unlike other laboratory tests, spirometry requires the participant’s full compliance with the maneuvers in the test for an acceptable test result. In this study, we aimed to determine the suitability of spirometric tests regarding acceptability and the factors associated with acceptability. Materials and Methods Before the test, our 15-scale questionnaire, prepared by us in the respiratory function laboratory, was applied to the participants who requested spirometric examination in our hospital. Afterwards, patients were subjected to spirometric analysis. Spirogram results of the participants were evaluated by four clinicians who were experts in the field based on the acceptability criteria in the American Thoracic Society and European Respiratory Society Spirometry Standardization Guidelines. Participants were divided into two groups as those who met the acceptability criteria and those who did not. Both groups were compared regarding demographic data, comorbidities, education levels, and questions in the questionnaire. Results The acceptability spirometry rate was 71.2%. The most common error among those who could not perform an acceptable test was the inability to complete the expiratory time to the time that would create a plateau, with 37.3%. Education level and acceptability of spirometry were not related (p= 0.228). Asthma was statistically significantly higher in the group that performed acceptable spirometry (p= 0.049). Acceptable spirometry rate was statistically significantly higher in the participants who had previously performed spirometric tests compared to the other group (p< 0.001). The test success of the participants who did not have success anxiety about the test was significantly higher than the other group (p= 0.033). Conclusion Reduction of participants’ anxiety and repetitive testing increases test acceptability. For this reason, in our clinical practice, we recommend that people who want a spirometry test relieve their anxiety about the test and repeat the test in unacceptable tests.

show abstract

Section: Discussionmentioning

confidence: 95%

Determining factors affecting the acceptability of spirometry: A survey study in a tertiary chest diseases center

Güçsav,

Polat,

Serçe Unat

et al. 2023

Tuberk Toraks

View full text Add to dashboard Cite

show abstract

“…The results showed that the number of attempts and the total time required of CA2122 was significantly lower than VERO. The shortening of FeNO measurement time was very important to improve the efficiency of pulmonary function room staff [34]. In this study, we defined more than five exhalations as failure.…”

Section: Discussionmentioning

confidence: 99%

The comparison of two exhaled nitric oxide analyzers: NIOX VERO and SUNVOU-CA2122

Lei

Tang

et al. 2021

J. Breath Res.

Self Cite

View full text Add to dashboard Cite

As a marker of eosinophilic airway inflammation, fractional exhaled nitric oxide (FeNO) was widely used in clinical practice. NIOX VERO (VERO) and SUNVOU-CA2122 (CA2122) are two commonly used eNO analyzers in China. However, what’s the difference and agreement between the two devices and whether the two types of devices can be replaced by each other in the application of common respiratory diseases have not been reported. The purpose of this study was to compare the two types of devices and to evaluate the difference between them in clinical use and whether they could be replaced. FeNO levels in 244 respiratory patients (including asthma, chronic obstructive pulmonary disease, chronic cough) were measured by CA2122 analyzer and VERO analyzer, respectively. The FeNO values obtained by the two devices were compared and the differences were analyzed. The success rate, the number of attempts and the total time required for a successful measurement by CA2122 and VERO were compared. The FeNO values measured by CA2122 online and offline were also compared. FeNO values obtained by CA2122 were slightly higher than those of VERO [median(range): 29.0(9–271) parts per billion (ppb) vs 25.5 (5–263) ppb, P = 0.000]. There was a high correlation between FeNO values measured by the two types of devices (r = 0.964, P = 0.000). By comparison, there was a high degree of agreement between the FeNO values measured by two devices, in all patients with different respiratory diseases. FeNO values measured online and offline by CA2122 were highly correlated and there was a high degree of agreement between online and offline methods. The success rate of CA2122 was higher than VERO, and the number of attempts (2.1 vs 2.4) and the total time (110.5 ± 35.7 vs 117.5 ± 48.1 s) required for a successful measurement by CA2122 were lower than those of VERO. CA2122 and VERO can be replaced by each other, and FeNO values can be converted if necessary. CA2122 has some advantages in success rate, the mean attempts and time required for successful measurement of FeNO.

show abstract

“…Individuals with COPD, pulmonary hypertension, interstitial lung disease, or other lung conditions often undergo this test. 22 Pulse oximetry, a noninvasive test, determines blood oxygen saturation by illuminating light at specific wavelengths into the tissue (https://www.verywellhealth.com/), 23 most frequently through the fingernail bed. A normal level is about 95% or more oxygen, while about 90% of patients with breathing problems or chronic lung illness may have normal levels.…”

Section: Functional Assessmentmentioning

confidence: 99%

A Clinical Review on Chronic Obstructive Pulmonary Disease

Suriyakumar,

Sivadasan,

Srinivass

et al. 2024

Future Integr Med

View full text Add to dashboard Cite

Chronic Obstructive Pulmonary Disease (COPD) is a prevalent and progressive respiratory disorder characterized by persistent airflow limitation, often associated with chronic bronchitis and emphysema. This abstract provides a comprehensive overview of COPD, emphasizing its clinical significance and impact on global health. COPD represents a significant public health concern, with escalating prevalence and mortality rates worldwide. Understanding epidemiological trends and risk factors is crucial for effective disease management and prevention strategies. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines serve as a compass in COPD management. It provides a comprehensive overview of the GOLD guidelines, elucidating their role in risk stratification, treatment escalation, and personalized care for individuals across varying disease severities. The management of COPD involves a multidimensional approach targeting symptom relief, improving lung function, and enhancing overall quality of life. Pharmacological interventions, such as bronchodilators and anti-inflammatory agents, play a pivotal role. Beyond conventional pharmacological treatments, various traditional therapies have gained attention in COPD management. These may include complementary and alternative medicine practices, such as acupuncture, herbal supplements, and yoga. While evidence supporting the efficacy of these interventions is still evolving, exploring their potential benefits. A comprehensive and integrative approach is crucial for optimizing COPD care and improving the lives of individuals affected by this intricate respiratory condition. This abstract concludes by encouraging continued collaboration among clinicians and patients to shape the future of COPD care. Ultimately fostering hope for improved outcomes and an enhanced prospect for those living with severe respiratory ailments.

show abstract

Safety and use of pulmonary function tests: a retrospective study from a single center over seven years’ clinical practice

Cited by 6 publications

References 19 publications

Determining factors affecting the acceptability of spirometry: A survey study in a tertiary chest diseases center

Determining factors affecting the acceptability of spirometry: A survey study in a tertiary chest diseases center

The comparison of two exhaled nitric oxide analyzers: NIOX VERO and SUNVOU-CA2122

A Clinical Review on Chronic Obstructive Pulmonary Disease

Contact Info

Product

Resources

About